These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9820002)

  • 21. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity.
    Santacroce R; Bossone A; Brancaccio V; Fortina P; Margaglione M
    Thromb Haemost; 2000 Jun; 83(6):963-4. PubMed ID: 10896257
    [No Abstract]   [Full Text] [Related]  

  • 22. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraindividual consistency of the activated protein C resistance phenotype.
    Tosetto A; Simioni M; Madeo D; Rodeghiero F
    Br J Haematol; 2004 Aug; 126(3):405-9. PubMed ID: 15257714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)].
    Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR
    Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factor V Leiden mutation. Successful outcome of a pregnancy after heparin therapy].
    Mazzarella CR; Del Bianco A; Pietropaolo F
    Minerva Ginecol; 2003 Feb; 55(1):81-5. PubMed ID: 12598848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
    Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I
    Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the geneticist in testing and counseling for inherited thrombophilia.
    Reich LM; Bower M; Key NS
    Genet Med; 2003; 5(3):133-43. PubMed ID: 12792420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis.
    Tjeldhorn L; Sandset PM; Haugbro K; Skretting G
    Thromb Res; 2010 Mar; 125(3):230-4. PubMed ID: 19535131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombophilia and cancer.
    Horowitz N; Brenner B
    Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital and acquired activated protein C resistance.
    Nicolaes GA; Dahlbäck B
    Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple phlebothrombosis following cesarean section due to heterozygous factor V Leiden mutation detected post partum].
    Grulich D; Schulze G; Riedel HH
    Zentralbl Gynakol; 1999; 121(11):526-9. PubMed ID: 10612220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Brain stem ischemia in a boy with resistance to C activated protein and elevated lipoprotein A].
    Sameiro-Barreirinho M; Costa E; Moreira A; Barbot J; Barbot C; Santos M
    Rev Neurol; 1999 Jun 1-15; 28(11):1061-4. PubMed ID: 10390775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inherited Thrombophilia due to Factor V Leiden Mutation.
    Mattson JC; Crisan D
    Mol Diagn; 1998 Mar; 3(1):55-61. PubMed ID: 10096958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [APC resistance--most frequent familial thrombophilia].
    Herren S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):499-501. PubMed ID: 10517118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial thrombophilia: genetic risk factors and management.
    Makris M; Rosendaal FR; Preston FE
    J Intern Med Suppl; 1997; 740():9-15. PubMed ID: 9350176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The concomitant presence of prohemorrhagic and thrombophilic changes in coagulation factor V: a severe defect of coagulant activity and homozygote resistance to activated protein C].
    Rossi V; Di Rocco N; Del Sonno C; Crivelli S
    Ann Ital Med Int; 1999; 14(2):127-9. PubMed ID: 10399376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.